Erythropoietin-derived peptide treatment reduced neurological deficit and neuropathological changes in a mouse model of tauopathy

BACKGROUND: Prominent activation of microglial immune/inflammatory processes is a characteristic feature of brains of patients with tauopathies including Alzheimer’s disease (AD), suggesting that neuroinflammation may be a critical factor in their pathogenesis. Strategies aimed at developing new the...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Yun-Beom, Dunn-Meynell, Ambrose A., Marchese, Michelle, Blumberg, Benjamin M., Gaindh, Deeya, Dowling, Peter C., Lu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839226/
https://www.ncbi.nlm.nih.gov/pubmed/33504364
http://dx.doi.org/10.1186/s13195-020-00766-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839226/
https://www.ncbi.nlm.nih.gov/pubmed/33504364
http://dx.doi.org/10.1186/s13195-020-00766-4

Ejemplares similares